Zobrazeno 1 - 10
of 29 353
pro vyhledávání: '"deoxyadenosine"'
Autor:
Xiong, Jian1 (AUTHOR) xiongjian@haust.edu.cn, Xu, Hanghang1 (AUTHOR), Wang, Qi1 (AUTHOR), Sun, Wenyuan1 (AUTHOR)
Publikováno v:
Molecules. May2023, Vol. 28 Issue 10, p4029. 12p.
Autor:
Bünsow, Dorothea1,2 (AUTHOR), Tantawy, Eshraq1,2 (AUTHOR), Ostermeier, Tjorven1,2 (AUTHOR), Bähre, Heike3 (AUTHOR), Garbe, Annette3 (AUTHOR), Larsen, Jesper4 (AUTHOR), Winstel, Volker1,2 (AUTHOR) winstel.volker@mh-hannover.de
Publikováno v:
Virulence. Dec 2021, Vol. 12 Issue 1, p989-1002. 14p.
Autor:
RASHEED, ASHRAF SAAD1 Ashraf_analytical@yahoo.com, QASSIM, AMEEN WALEED2, ABDULRAHMAN, SALSAL KAMAL2
Publikováno v:
International Journal of Pharmaceutical Research (09752366). 2020 Supplement2, p318-326. 9p.
Autor:
Ole Kristian Greiner-Tollersrud, Máté Krausz, Vincent Boehler, Aikaterini Polyzou, Maximilian Seidl, Ambra Spahiu, Zeinab Abdullah, Katarzyna Andryka-Cegielski, Felix Immunuel Dominick, Katrin Huebscher, Andreas Goschin, Cristian R. Smulski, Eirini Trompouki, Regina Link, Hilmar Ebersbach, Honnappa Srinivas, Martine Marchant, Georgios Sogkas, Dieter Staab, Cathrine Vågbø, Danilo Guerini, Sebastian Baasch, Eicke Latz, Gunther Hartmann, Philippe Henneke, Roger Geiger, Xiao P. Peng, Bodo Grimbacher, Eva Bartok, Ingrun Alseth, Max Warncke, Michele Proietti
Publikováno v:
Cell Reports, Vol 43, Iss 11, Pp 114899- (2024)
Summary: Although adenosine deaminase 2 (ADA2) is considered an extracellular ADA, evidence questions the physiological relevance of this activity. Our study reveals that ADA2 localizes within the lysosomes, where it is targeted through modifications
Externí odkaz:
https://doaj.org/article/f6e14d70f0b648c3aca83261512b83d8
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Greiner-Tollersrud OK; Institute of Medical Biology, University of Tromsø, Tromsø, Norway., Krausz M; Institute for Immunodeficiency, Center for Chronic Immunodeficiency, Medical Center, Faculty of Medicine, Albert-Ludwigs-University of Freiburg, Freiburg im Breisgau, Germany., Boehler V; Novartis Institutes for Biomedical Research, 4056 Basel, Switzerland., Polyzou A; Max Planck Institute of Immunobiology and Epigenetics, Freiburg, Germany; IRCAN Institute for Research on Cancer and Aging, INSERM Unité 1081, CNRS UMR 7284, Université Côte d'Azur, Nice, France., Seidl M; Institute of Pathology, University Hospital of Düsseldorf, Düsseldorf, Germany., Spahiu A; Institute for Immunodeficiency, Center for Chronic Immunodeficiency, Medical Center, Faculty of Medicine, Albert-Ludwigs-University of Freiburg, Freiburg im Breisgau, Germany., Abdullah Z; Institute of Experimental Immunology, Universitätsklinikum Bonn, Bonn, Germany., Andryka-Cegielski K; Institute of Experimental Hematology and Transfusion Medicine Bonn, Bonn, Germany., Dominick FI; Institute of Experimental Hematology and Transfusion Medicine Bonn, Bonn, Germany., Huebscher K; Institute for Immunodeficiency, Center for Chronic Immunodeficiency, Medical Center, Faculty of Medicine, Albert-Ludwigs-University of Freiburg, Freiburg im Breisgau, Germany; Institut für Forstentomologie und Waldschutz, Albert-Ludwigs-University of Freiburg, Freiburg im Breisgau, Germany., Goschin A; Institute for Immunodeficiency, Center for Chronic Immunodeficiency, Medical Center, Faculty of Medicine, Albert-Ludwigs-University of Freiburg, Freiburg im Breisgau, Germany., Smulski CR; Medical Physics Department, Centro Atómico Bariloche, Comisión Nacional de Energía Atómica (CNEA), Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), San Carlos de Bariloche, Río Negro, Argentina., Trompouki E; Max Planck Institute of Immunobiology and Epigenetics, Freiburg, Germany; IRCAN Institute for Research on Cancer and Aging, INSERM Unité 1081, CNRS UMR 7284, Université Côte d'Azur, Nice, France., Link R; Novartis Institutes for Biomedical Research, 4056 Basel, Switzerland., Ebersbach H; Novartis Institutes for Biomedical Research, 4056 Basel, Switzerland., Srinivas H; Novartis Institutes for Biomedical Research, 4056 Basel, Switzerland., Marchant M; Novartis Institutes for Biomedical Research, 4056 Basel, Switzerland., Sogkas G; Department of Rheumatology and Clinical Immunology, Hannover Medical School, Carl-Neuberg-Str. 1, 30625 Hannover, Germany; RESIST - Cluster of Excellence 2155, Hannover Medical School, Carl-Neuberg-Str. 1, 30625 Hannover, Germany., Staab D; Novartis Institutes for Biomedical Research, 4056 Basel, Switzerland., Vågbø C; Proteomics and Modomics Experimental Core (PROMEC), Norwegian University of Science and Technology and the Central Norway Regional Health Authority, Trondheim, Norway., Guerini D; Novartis Institutes for Biomedical Research, 4056 Basel, Switzerland., Baasch S; Institute for Immunodeficiency, Center for Chronic Immunodeficiency, Medical Center, Faculty of Medicine, Albert-Ludwigs-University of Freiburg, Freiburg im Breisgau, Germany; Institute for Infection Prevention and Control, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany; Freiburg Institute for Advanced Studies (FRIAS), University of Freiburg, Freiburg, Germany., Latz E; Institute of Innate Immunity, Universitätsklinikum Bonn, Bonn, Germany., Hartmann G; Institute of Experimental Hematology and Transfusion Medicine Bonn, Bonn, Germany., Henneke P; Institute for Immunodeficiency, Center for Chronic Immunodeficiency, Medical Center, Faculty of Medicine, Albert-Ludwigs-University of Freiburg, Freiburg im Breisgau, Germany; Institute for Infection Prevention and Control, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany., Geiger R; Institute for Research in Biomedicine, Università della Svizzera italiana, Bellinzona, Switzerland; Institute of Oncology Research, Università della Svizzera italiana, Bellinzona, Switzerland., Peng XP; Department of Genetic Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Grimbacher B; Institute for Immunodeficiency, Center for Chronic Immunodeficiency, Medical Center, Faculty of Medicine, Albert-Ludwigs-University of Freiburg, Freiburg im Breisgau, Germany; RESIST - Cluster of Excellence 2155 to Hanover Medical School, Satellite Center Freiburg, Freiburg, Germany., Bartok E; Institute of Experimental Hematology and Transfusion Medicine Bonn, Bonn, Germany., Alseth I; Department of Microbiology, Oslo University Hospital, Oslo, Norway., Warncke M; Novartis Institutes for Biomedical Research, 4056 Basel, Switzerland., Proietti M; Institute for Immunodeficiency, Center for Chronic Immunodeficiency, Medical Center, Faculty of Medicine, Albert-Ludwigs-University of Freiburg, Freiburg im Breisgau, Germany; Department of Rheumatology and Clinical Immunology, Hannover Medical School, Carl-Neuberg-Str. 1, 30625 Hannover, Germany; RESIST - Cluster of Excellence 2155, Hannover Medical School, Carl-Neuberg-Str. 1, 30625 Hannover, Germany. Electronic address: michele.proietti@uniklinik-freiburg.de.
Publikováno v:
Cell reports [Cell Rep] 2024 Oct 22; Vol. 43 (11), pp. 114899. Date of Electronic Publication: 2024 Oct 22.
Autor:
Dai, Jiao1,2,3, Lai, Liying1,2,3, Tang, Huanyu1,2,3, Wang, Weixue1,2,3, Wang, Shuoyue1,2,3, Lu, Chengping1,2,3, Yao, Huochun1,2,3, Fan, Hongjie1,2,4, Wu, Zongfu1,2,3 wuzongfu@njau.edu.cn
Publikováno v:
Virulence. 2018, Vol. 9 Issue 1, p1509-1520. 12p.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Dorothea Bünsow, Eshraq Tantawy, Tjorven Ostermeier, Heike Bähre, Annette Garbe, Jesper Larsen, Volker Winstel
Publikováno v:
Virulence, Vol 12, Iss 1, Pp 989-1002 (2021)
Methicillin-resistant Staphylococcus pseudintermedius (MRSP) is an emerging zoonotic pathogen of canine origin that causes an array of fatal diseases, including bacteremia and endocarditis. Despite large-scale genome sequencing projects have gained s
Externí odkaz:
https://doaj.org/article/be6bbdd3d8d24be2a325ac0aee5177c2
Publikováno v:
Molecules, Vol 28, Iss 10, p 4029 (2023)
Deoxyadenosine triphosphate (dATP) is an important biochemical molecule. In this paper, the synthesis of dATP from deoxyadenosine monophosphate (dAMP), catalyzed by Saccharomyces cerevisiae, was studied. By adding chemical effectors, an efficient ATP
Externí odkaz:
https://doaj.org/article/d74771bed1374d9c85ee90971cb28642